News Detail

Chairman Senate  Syed Yousuf Raza Gilani, attended the 8th Pakistan Pharma Summit and the 4th Pharma Export Summit & Awards (PESA 2025) today as the Chief Guest. The event was organized by the Pakistan Pharmaceutical Manufacturers’ Association (PPMA) and brought together leading pharmaceutical exporters, industry leaders, policymakers, and international experts.

The Chairman Senate was warmly received by Mr. Tauqeer Ul Haq, Chairman PPMA, Dr. Kaiser Waheed, Chairman Organizing Committee, and Co-Chairmen Mr. Haroon Qasim and Mr. Asad Shuja.

In his keynote address, Chairman Senate Syed Yousuf Raza Gilani congratulated the top 50 exporters of pharmaceuticals and allied products who were recognized through the prestigious PESA Awards. He lauded their role in strengthening Pakistan’s position in the global healthcare sector and described them as the “torchbearers of Pakistan’s growing stature in international markets.”

He highlighted that Pakistan’s pharmaceutical exports had reached a record USD 457 million in the last fiscal year, registering a 34% growth — the highest increase in over two decades. He termed this a matter of national pride, emphasizing that Pakistan now meets the vast majority of its pharmaceutical needs through local production.

Acknowledging the sector’s transformation, Mr. Gilani noted the early adoption of artificial intelligence, digital health platforms, and advanced manufacturing technologies, along with supportive institutional efforts such as reducing duties on Active Pharmaceutical Ingredients (APIs) and the launch of PharmEx Pakistan.

He assured the industry of Parliament’s all-out support, stating that through the relevant Committees in both the Senate and the National Assembly, the government remains committed to enabling better legislation, aligning conducive policies, and encouraging investment in research and development.

Welcoming international experts and speakers, the Chairman underlined the importance of global partnerships, technology transfer, and adherence to international certifications, including those from the World Health Organization (WHO), for expanding Pakistan’s footprint in advanced markets.

“The way forward lies in a progressive approach that links innovation, collaboration, and sustainability,” Mr. Gilani stressed, adding that with resilience and determination, Pakistan’s pharmaceutical industry could claim a much larger share of the trillion-dollar global pharmaceutical market.

He concluded by congratulating the PPMA leadership and all award recipients, reaffirming that their contributions are vital to building a stronger and healthier Pakistan, and pledged continued support from the Senate of Pakistan in this national cause.

“Together, let us make Pakistan a trusted name in global healthcare.”

Pakistan Zindabad